Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy E Rudolph

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Kidney International|April 5, 2003
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive ratsEileen R Blasi, Ricardo Rocha, Amy E Rudolph, et al.
Journal of Cardiac Failure|February 18, 2004
Role of a selective aldosterone blocker in mice with chronic heart failureDahai Wang, Yun-He Liu, Xiao-Ping Yang, et al.
Journal of Cardiac Failure|February 11, 2005
Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarctionYun-He Liu, Dahai Wang, Nour-Eddine Rhaleb, et al.
Circulation Research|June 7, 2003
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureWenning Qin, Amy E Rudolph, Brian R Bond, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2002
Aldosterone induces a vascular inflammatory phenotype in the rat heartRicardo Rocha, Amy E Rudolph, Gregory E Frierdich, et al.
Stroke|October 27, 2007
Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialPierre Amarenco, Larry B Goldstein, Michael Szarek, et al.
Circulation|December 4, 2002
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failureGeorge Suzuki, Hideaki Morita, Takayuki Mishima, et al.
The New England Journal of Medicine|August 11, 2006
High-dose atorvastatin after stroke or transient ischemic attackPierre Amarenco, Julien Bogousslavsky, Alfred Callahan, et al.
Journal of Cardiac Failure|October 8, 2004
Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarctionSerge Masson, Lidia Staszewsky, Giorgio Annoni, et al.
Atherosclerosis|October 31, 2008
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialPierre Amarenco, Larry B Goldstein, Alfred Callahan, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Kidney International|April 5, 2003
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive ratsEileen R Blasi, Ricardo Rocha, Amy E Rudolph, et al.
Journal of Cardiac Failure|February 18, 2004
Role of a selective aldosterone blocker in mice with chronic heart failureDahai Wang, Yun-He Liu, Xiao-Ping Yang, et al.
Journal of Cardiac Failure|February 11, 2005
Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarctionYun-He Liu, Dahai Wang, Nour-Eddine Rhaleb, et al.
Circulation Research|June 7, 2003
Transgenic model of aldosterone-driven cardiac hypertrophy and heart failureWenning Qin, Amy E Rudolph, Brian R Bond, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 18, 2002
Aldosterone induces a vascular inflammatory phenotype in the rat heartRicardo Rocha, Amy E Rudolph, Gregory E Frierdich, et al.
Stroke|October 27, 2007
Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialPierre Amarenco, Larry B Goldstein, Michael Szarek, et al.
Circulation|December 4, 2002
Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failureGeorge Suzuki, Hideaki Morita, Takayuki Mishima, et al.
The New England Journal of Medicine|August 11, 2006
High-dose atorvastatin after stroke or transient ischemic attackPierre Amarenco, Julien Bogousslavsky, Alfred Callahan, et al.
Journal of Cardiac Failure|October 8, 2004
Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarctionSerge Masson, Lidia Staszewsky, Giorgio Annoni, et al.
Atherosclerosis|October 31, 2008
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialPierre Amarenco, Larry B Goldstein, Alfred Callahan, et al.
Pageof 3